methylation blood test Options
Application of this technology for the broader affected person populations will rely on the rate of discovery of gene and ailment-unique episignatures. being a corollary, implementation of chromosomal microarrays as a primary-tier diagnostic test was mainly contingent on amplified diagnostic generate in comparison with karyotyping (from 5% to 10–